Investment Value Analysis of Huaxia CSI Biotechnology Theme ETF: Triple Resonance of Policy, Valuation, and Overseas Expansion

Innovative drug sector: Driven by demand and policy support, globalization opportunities are becoming increasingly prominent. (1) Continuous improvement in policy support has ushered innovative drugs into a new dawn. On the R&D front, the domestic drug evaluation thresholds have steadily increased, and the industry's overall R&D capabilities continue to strengthen.

Guosheng SecuritiesNov 21 19:32

A Comprehensive Overview of the Core Directions of the 15th Five-Year Plan and Related ETFs!

Historic transformation

Gelonghui FinanceOct 30 17:42

Blackrock: As expectations for interest rate cuts mount, inflows into equity ETFs have surged significantly.

Gelonghui, September 16 — Wu Yuxi, Head of iShares Equity Product Strategy for Asia Pacific at BlackRock, stated that over the past year, there has been an increase in demand for ETFs in the US, Europe, and even Asian markets. The scale of global ETF inflows continues to grow, especially since June, when the market began to anticipate interest rate cuts, leading to a significant rise in inflows into equity-type ETFs. He noted that expectations of interest rate cuts have also driven growth in fixed-income ETFs, but the growth has mainly been concentrated in short-duration ETFs. Regarding industry-specific ETFs, he remains optimistic about the performance of artificial intelligence and technology sectors. Additionally, biotechnology, finance, and industrial sectors have also benefited from the expectation of interest rate cuts.

Gelonghui FinanceSep 16 09:44

ETF Review | A-shares lost the 3,700-point level, with cross-border ETFs leading the gains in the afternoon; the S&P Biotech ETF and the Nasdaq Biotech ETF rose more than 2%.

Gelonghui, August 14 | The Shanghai Composite Index rose and then fell, closing down 0.46%. During the session, it broke through 3,700 points, reaching a four-year high. The STAR 50 Index rose 0.75%. The total trading volume for the full day in the Shanghai, Shenzhen, and Beijing markets was 2.3063 trillion yuan, an increase of 131.1 billion yuan from the previous day, setting a new record for the year. Over 4,600 stocks declined. Strong trend sectors collectively adjusted, with CPO, PCB, and military informatization concepts leading the declines, while Xinjiang and super-hard materials concepts remained weak. Stablecoin concepts saw a significant rise, with GPU and insurance stocks performing well, and the brain-computer interface sector also gained. In ETFs, overnight U.S. stocks continued to rise, and Harvest Fund's S&P Biotechnology

Gelonghui FinanceAug 14 15:11

Analysis of the investment value of the Huaxia CSI Biotechnology Theme ETF Funds: Demand-driven combined with policy empowerment.

Innovative pharmaceuticals: Demand-driven policies empower opportunities for globalization: (1) The demand side urgently needs structural upgrades, as population aging drives the continuous release of essential medical needs. China has entered a deeply aging society, and the situation of aging in our country will become even more severe in the future.

Guosheng SecuritiesJul 1 00:00

Tariff negotiations exceeded expectations, and the Hong Kong stock market's Innovative Drugs Sector rebounded accordingly, with BEIGENE rising over 6%.

Gelonghui, May 13 | Overnight, the overall biotechnology Sector in the USA rose, with the affordable weight-loss drug company Hims increasing by nearly 6%. Eli Lilly and Co initially fell nearly 1.7% but then turned to growth. Today, the Innovative Drugs Sector in Hong Kong rebounded, with BEIGENE, 3SBIO, and REMEGEN rising by 6.89%, 5.53%, and 4.94% respectively. Trump signed an executive order, claiming to reduce USA drug prices by 50% to 80%, or even 90%. Analysts say the language of the executive order is vague, with almost no specific implementation details, believing the execution will be difficult and not as troubling as expected by pharmaceutical companies. Based on market performance, influenced by the USA's intention to impose tariffs on May 5.

Gelonghui FinanceMay 13 09:36